Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise INCHEON, South Korea, Jan. 9, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract...
World-renowned Illusionist Franz Harary's Grand-scale Magic Show "IMAGINE NATION" Extends Showings to February 4 Due to Overwhelming Popularity
Celebrate the Season's Festivities With the Wonders of Magic HONG KONG, Dec. 28, 2024 /PRNewswire/ -- This winter, the world's top magician, creator of stunning grand-scale illusions, and pioneer in technological stage production Franz Harary has...
Jianpu Technology Inc. Extends Its Share Repurchase Program
BEIJING, Dec. 23, 2024 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China, today announced that its board of directors (the "Board") has approved an extension of...
Maropost extends its "High Performer" streak in G2 Winter Reports while earning new "Easiest to Use" badge
Marketing Cloud reinforces mid-market excellence in marketing automation across seven categories and 71 reports. TORONTO, Dec. 19, 2024 /PRNewswire/ -- A perennial "High Performer," Maropost Marketing Cloud broke new ground in G2's Winter 2025...
JinkoSolar Upsizes and Extends Share Repurchase Program
SHANGRAO, China, Dec. 11, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its board of directors...
Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Huntington's Disease Volumetric MRI measurement is also approved as exploratory study endpoint BOSTON,...